Berry Genomics Co.,Ltd (SHE:000710)
China · Delayed Price · Currency is CNY 9.57
-0.42 (-4.20%)
Aug 11, 2026, 3:04 PM CST
Berry Genomics Co.,Ltd Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 3,532 | 3,991 | 2,987 | 4,073 | 4,034 | 6,804 | |
Market Cap Growth | -32.45% | 33.61% | -26.65% | 0.96% | -40.71% | -49.03% |
Enterprise Value | 3,555 | 3,993 | 2,894 | 4,164 | 4,122 | 6,884 |
Last Close Price | 9.99 | 11.29 | 8.45 | 11.52 | 11.41 | 19.40 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Forward PE | - | 39.28 | 39.28 | 39.28 | 39.28 | 51.73 |
PS Ratio | 3.83 | 4.29 | 2.77 | 3.54 | 2.95 | 4.78 |
PB Ratio | 2.34 | 2.65 | 1.74 | 2.15 | 1.73 | 2.70 |
P/TBV Ratio | 2.57 | 2.86 | 1.83 | 2.26 | 1.80 | 2.81 |
P/FCF Ratio | - | - | 95.70 | 72.85 | - | - |
P/OCF Ratio | 260.28 | 56.53 | 33.96 | 36.69 | 190.46 | 72.35 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 3.85 | 4.29 | 2.68 | 3.62 | 3.01 | 4.84 |
EV/EBITDA Ratio | - | - | - | - | - | 135.14 |
EV/FCF Ratio | - | - | 92.70 | 74.48 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.18 | 0.18 | 0.09 | 0.16 | 0.15 | 0.16 |
Debt / EBITDA Ratio | - | - | - | - | - | 6.66 |
Debt / FCF Ratio | - | - | 5.14 | 5.43 | - | - |
Net Debt / Equity Ratio | -0.02 | -0.07 | -0.14 | -0.03 | 0.00 | -0.01 |
Net Debt / EBITDA Ratio | 0.27 | 0.98 | 5.67 | 0.49 | -0.30 | -0.44 |
Net Debt / FCF Ratio | 0.55 | 21.51 | -7.68 | -0.87 | -0.19 | 0.09 |
Asset Turnover | 0.40 | 0.40 | 0.42 | 0.39 | 0.41 | 0.42 |
Inventory Turnover | 2.98 | 2.99 | 2.85 | 2.90 | 3.54 | 4.00 |
Quick Ratio | 1.63 | 1.55 | 1.98 | 1.54 | 2.01 | 2.04 |
Current Ratio | 2.10 | 1.96 | 2.44 | 1.93 | 2.45 | 2.48 |
Return on Equity (ROE) | -13.05% | -12.20% | -10.43% | -20.14% | -10.15% | -4.44% |
Return on Assets (ROA) | -5.11% | -4.67% | -2.91% | -4.18% | -2.33% | -0.86% |
Return on Invested Capital (ROIC) | -13.20% | -12.17% | -7.19% | -9.50% | -5.19% | -2.00% |
Return on Capital Employed (ROCE) | -11.40% | -10.60% | -6.70% | -10.10% | -5.00% | -1.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | -5.95% | -4.93% | -6.44% | -10.49% | -6.17% | -1.63% |
FCF Yield | -1.78% | -0.13% | 1.04% | 1.37% | -1.29% | -3.57% |
Buyback Yield / Dilution | -7.12% | 0.00% | -0.00% | -15.04% | 14.03% | -0.12% |